Chlorine in PDB 7nxk: Crystal Structure of Human CDK12/Cyclin K in Complex with the Inhibitor Bsj-01-175

Enzymatic activity of Crystal Structure of Human CDK12/Cyclin K in Complex with the Inhibitor Bsj-01-175

All present enzymatic activity of Crystal Structure of Human CDK12/Cyclin K in Complex with the Inhibitor Bsj-01-175:
2.7.11.22; 2.7.11.23;

Protein crystallography data

The structure of Crystal Structure of Human CDK12/Cyclin K in Complex with the Inhibitor Bsj-01-175, PDB code: 7nxk was solved by K.Anand, S.Dust, I.H.Kaltheuner, M.Geyer, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 49.00 / 3.00
Space group P 1
Cell size a, b, c (Å), α, β, γ (°) 50.21, 77.46, 91.53, 103.61, 85.89, 102.56
R / Rfree (%) 22 / 26.4

Chlorine Binding Sites:

The binding sites of Chlorine atom in the Crystal Structure of Human CDK12/Cyclin K in Complex with the Inhibitor Bsj-01-175 (pdb code 7nxk). This binding sites where shown within 5.0 Angstroms radius around Chlorine atom.
In total 2 binding sites of Chlorine where determined in the Crystal Structure of Human CDK12/Cyclin K in Complex with the Inhibitor Bsj-01-175, PDB code: 7nxk:
Jump to Chlorine binding site number: 1; 2;

Chlorine binding site 1 out of 2 in 7nxk

Go back to Chlorine Binding Sites List in 7nxk
Chlorine binding site 1 out of 2 in the Crystal Structure of Human CDK12/Cyclin K in Complex with the Inhibitor Bsj-01-175


Mono view


Stereo pair view

A full contact list of Chlorine with other atoms in the Cl binding site number 1 of Crystal Structure of Human CDK12/Cyclin K in Complex with the Inhibitor Bsj-01-175 within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Cl2000

b:108.5
occ:1.00
CL1 A:UUB2000 0.0 108.5 1.0
C15 A:UUB2000 1.8 73.5 1.0
C10 A:UUB2000 2.7 76.8 1.0
C14 A:UUB2000 2.7 66.6 1.0
C9 A:UUB2000 3.0 83.5 1.0
C8 A:UUB2000 3.1 91.8 1.0
CB A:ALA754 3.5 70.8 1.0
CB A:PHE813 3.8 82.4 1.0
N11 A:UUB2000 3.9 77.0 1.0
N13 A:UUB2000 4.0 68.1 1.0
C5 A:UUB2000 4.0 88.2 1.0
N7 A:UUB2000 4.1 96.7 1.0
CG A:PHE813 4.2 84.2 1.0
CD1 A:PHE813 4.3 75.0 1.0
C12 A:UUB2000 4.5 74.2 1.0
C4 A:UUB2000 4.6 81.1 1.0
H39 A:UUB2000 4.6 116.0 1.0
O A:GLU814 4.8 92.4 1.0
CD1 A:LEU866 4.8 72.7 1.0
CA A:ALA754 4.9 72.5 1.0
C6 A:UUB2000 4.9 87.7 1.0
CG1 A:VAL741 5.0 81.1 1.0

Chlorine binding site 2 out of 2 in 7nxk

Go back to Chlorine Binding Sites List in 7nxk
Chlorine binding site 2 out of 2 in the Crystal Structure of Human CDK12/Cyclin K in Complex with the Inhibitor Bsj-01-175


Mono view


Stereo pair view

A full contact list of Chlorine with other atoms in the Cl binding site number 2 of Crystal Structure of Human CDK12/Cyclin K in Complex with the Inhibitor Bsj-01-175 within 5.0Å range:
probe atom residue distance (Å) B Occ
C:Cl2000

b:89.5
occ:1.00
CL1 C:UUB2000 0.0 89.5 1.0
C15 C:UUB2000 1.8 93.1 1.0
C14 C:UUB2000 2.7 92.0 1.0
C10 C:UUB2000 2.7 93.8 1.0
C8 C:UUB2000 2.9 94.4 1.0
C9 C:UUB2000 3.1 92.8 1.0
CB C:PHE813 3.5 88.2 1.0
CG C:PHE813 3.9 87.6 1.0
N13 C:UUB2000 3.9 91.5 1.0
N11 C:UUB2000 3.9 94.0 1.0
N7 C:UUB2000 4.2 99.5 1.0
CD2 C:PHE813 4.3 85.3 1.0
CD1 C:LEU866 4.3 82.7 1.0
CG2 C:VAL787 4.3 80.2 1.0
CB C:ALA754 4.4 94.7 1.0
C12 C:UUB2000 4.4 91.0 1.0
CD1 C:PHE813 4.5 79.9 1.0
C5 C:UUB2000 4.5 92.3 1.0
H39 C:UUB2000 4.6 119.3 1.0
O C:GLU814 4.7 104.5 1.0
CA C:PHE813 4.9 85.8 1.0
C4 C:UUB2000 5.0 93.9 1.0

Reference:

B.Jiang, J.Jiang, I.H.Kaltheuner, A.B.Iniguez, K.Anand, F.M.Ferguson, S.B.Ficarro, B.K.A.Seong, A.K.Greifenberg, S.Dust, N.P.Kwiatkowski, J.A.Marto, K.Stegmaier, T.Zhang, M.Geyer, N.S.Gray. Structure-Activity Relationship Study of THZ531 Derivatives Enables the Discovery of Bsj-01-175 As A Dual CDK12/13 Covalent Inhibitor with Efficacy in Ewing Sarcoma. Eur.J.Med.Chem. V. 221 13481 2021.
ISSN: ISSN 0223-5234
PubMed: 33945934
DOI: 10.1016/J.EJMECH.2021.113481
Page generated: Tue Jul 30 01:08:59 2024

Last articles

Zn in 9JPJ
Zn in 9JP7
Zn in 9JPK
Zn in 9JPL
Zn in 9GN6
Zn in 9GN7
Zn in 9GKU
Zn in 9GKW
Zn in 9GKX
Zn in 9GL0
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy